Planning ahead prevents missed doses during travel
Potential for Hypoglycemia: While not common, there is a risk of hypoglycemia (low blood sugar), especially when Tirzepatide is used in combination with other glucose-lowering medications like insulin or sulfonylureas
The discovery of robust predictors of treatment response could enable the prediction, from the outset, of a persons probable treatment journey, and thereby pave the way for precision medicine through the clinical implementation of combined phenotypic and genotypic prediction models
And since fat provides the main energy fuel for muscles, tapping into your body's fat stores is critical
[PMID 38958939, PMID 39976940, PMID 42060879] CONTRAINDICATIONS A personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) A prior serious hypersensitivity reaction to semaglutide or to any of the excipients in Wegovy PRECAUTIONS Kidney disease No dose adjustment is necessary for any degree of renal impairment Liver disease No dose adjustment is necessary for any degree of hepatic impairment Stomach disorders Wegovy slows gastric emptying and is not recommended in patients with significant stomach disorders, including diabetic gastroparesis General anesthesia or deep sedation GLP-1 therapies, like Wegovy, slow gastric emptying, possibly increasing the risk of residual gastric contents and pulmonary aspiration in patients receiving anesthesia or deep sedation for procedures